期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

RNA编辑与肿瘤 被引量：2

下载PDF
导出
作者 杨朝华 田宇 安治国
机构地区 北海市人民医院 吉林大学中日联谊医院
出处 《中国实验诊断学》 2004年第1期89-91,共3页 Chinese Journal of Laboratory Diagnosis
基金 国家自然科学基金资助项目 (编号 3 0 2 713 3 4)
关键词 RNA编辑 肿瘤 神经纤维瘤 谷氨酰胺
分类号 R730.2 [医药卫生—肿瘤]
  • 相关文献

参考文献21

  • 1[1]Benne R, Van den Burg J, Brakenhoff JP, et al Major transcript of the frameshifted coxll gene from trypanosome mitochondria contains four nucleotides that are not encoded in the DNA [J]. Cell, 1986,46(6) :819.
  • 2[2]Ashkenas J. Gene regulation by mRNA editing [J]. Am J Hum Genet,1997,60(20) :278.
  • 3[3]SharmaP, Bowman M, MaddenS, etal. RNA editing in the Wilms' tumor susceptibility gene, WT1 [J]. Gene Dev, 1994,8:720.
  • 4[4]Novo F, Kruszweski A, MacDermor K, et al. Editing of human a-galactosidase RNA resulting in a primidime to purine conversion [J]. Nucleic Acids Res, 1995,23:2636.
  • 5[5]Anant S, Henderson JO, Mukhopadhyay D, et al. Novcl role for RNAbinding protein CUGBP2 in manmmalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor [J]. J Biol Chem, 2001,276(50) :47338.
  • 6[6]Chen Z, Eggeman TL, Paterson AP. Phosogirylation is a regulatory mechanism in apolipoprotein B mRNA editing [J]. Biochem J, 2001,357(Pt 3) :661.
  • 7[7]Melcher T, Maas S, Herb A, et al. A mammalian RNA editing enzyme [J]. Nature, 1996,379(6564):460.
  • 8[8]Melcher T, Maas S, Herb A, et al. RED2 a brain specific member of the adenosine deaminase family [J]. J Biol Chem, 1996,271(50):31795.
  • 9[9]Cappione AJ, French BL, Skuse GR. A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors [J]. Am J Hum Genet, 1997,60(2):305.
  • 10[10]Mukhopadhyay D, Anant S, Lee RM, et al. C → U editing of neurofibromatosis 1 mRNA occurs in tumors that express the type Ⅱ transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme [J]. Am J Hum Genet, 2002,70(1):38.

同被引文献49

  • 1Scholzova E, Malik R, Sevcik J, et al. RNA regulation and cancer development. Cancer Lett, 2007, 246: 12-23.
  • 2Decher N, Netter MF, Streit AK. Putative impact of RNA editing on drug discovery. Chem Biol Drug Des, 2013, 81: 13-21.
  • 3Gray MW. Evolutionary origin of RNA editing. Biochemistry, 2012,51: 5235-42.
  • 4Savva YA, Rieder LE, Reenan RA. The ADAR protein family. Genome Biol, 2012, 13: 252.
  • 5Smith HC, Bennett RP, Kizilyer A, et al. Functions and regulation of the APOBEC family of proteins. Semin Cell Dev Biol, 2012, 23: 258-68.
  • 6Avesson L, Barry G. The emerging role of RNA and DNA editing in cancer. Biochim Biophys Acta, 2014,1845: 308-16.
  • 7Qi L, Chan TH, Tenen DG, et al. RNA editome imbalance in hepatocellular carcinoma. Cancer Res, 2014, 74: 1301-6.
  • 8Chen L, Li Y, Lin CH, et al. Recoding RNA editing of AZlNl predisposes to hepatocellular carcinoma. Nat Med, 2013, 19: 209-16.
  • 9Chan TH, Lin CH, Qi L, et al. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma. Gut, 2014,63: 832-43.
  • 10Liu WH, Chen CH, Yeh KH, et al. ADAR2-mediated editing of miR - 214 and miR -122 precursor and antisense RNA transcripts in liver cancers. PLoS One, 2013, 8: e81922.

引证文献2

二级引证文献3

中国实验诊断学
2004年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部